Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
InMed Pharmaceuticals Inc. (NASDAQ: INM)
INM Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-5%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
INM Stock Analysis
INM
PE Ratio:
INM
PEG Ratio:
Not Available
INM
Forward EPS Growth (12 month):
0.00%
INM
PS Ratio:
0.9
INM
PSG Ratio:
Not Available
INM
Forward Revenue Growth (12 month):
0.00%
INM Articles
No data was found